Canine prostate carcinoma: Epidemiological evidence of an increased risk in castrated dogs

Molecular and Cellular Endocrinology

Volumn 197, Issue 1-2, 2002, Pages 251-255

  Teske, E ^a   Naan, E C ^a   Van Dijk, E M ^a   Van Garderen, E ^b   Schalken, J A ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Androgen depletion; Dog; Prostate carcinoma; Risk factors

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CASTRATION; CONTROLLED STUDY; DOG; HIGH RISK POPULATION; HISTOPATHOLOGY; MALE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATITIS; TUMOR GROWTH; VETERINARY MEDICINE; AGE; ANIMAL; ANIMAL DISEASE; DOG DISEASE; ORCHIECTOMY; PROSTATE DISEASE; PROSTATE TUMOR; RETROSPECTIVE STUDY; RISK FACTOR;

AGE FACTORS; ANIMALS; DOG DISEASES; DOGS; MALE; ORCHIECTOMY; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037195538     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00261-7     Document Type: Article

References (30)

1. Aquilina J.W., McKinney L., Pacelli A., Richman L.K., Waters D.J., Thompson I., Burghardt W.F. Jr., Botwick D.G. High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer. Prostate. 36:1998;189-193.
2. Bell F.W., Klausner J.S., Hayden D.W., Feeney D.A., Johnston S.D. Clinical and pathological features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987). J. Am. Vet. Med. Assoc. 199:1991;1623-1630.
3. Bell F.W., Klausner J.S., Hayden D.W., Lund E.M., Liebenstein B.B., Feeney D.A., Johnston S.D., Shivers J.L., Ewing C.M., Isaacs W.B. Evaluation of serum and seminal plasma markers of canine prostatic disorders. J. Vet. Int. Med. 9:1995;149-153.
4. Bostwick D.G. High grade prostatic intraepithelial neoplasia; the most likely precursor of prostate cancer. Cancer. 75:(Suppl.):1995;1823-1836.
5. Bui M., Reiter R.E. Stem cell genes in androgen-independent prostate cancer. Cancer Metastasis Rev. 17:1999;391-399.
6. Chodak G.W., Thisted R.A., Gerber G.S., Johansson J.E., Adolfsson J., Jones G.W., Chisholm G.D., Moskovitz B., Livne P.M., Warner J. Results of conservative management of clinically localised prostate cancer. N. Engl. J. Med. 330:1994;242-248.
7. Coffey D.S. Similarities of prostate and breast cancer: evolution, diet, and estrogens. Urology. 57:(Suppl. 4A):2001;31-38.
8. Cornell K.K., Bostwick D.G., Cooley D.M., Hall G., Harvey H.J., Hendrick M.J., Pauli B.U., Render J.A., Stoica G., Sweet D.C., Waters D.J. Clinical and pathological aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate. 45:2000;173-183.
9. Craft N., Sawyers C.L. Mechanistic concepts in androgen-dependence of prostate cancer. Cancer Metastasis Rev. 17:1999;421-427.
10. Johnston S.D., Kamolpatana K., Root-Kustritz M.V., Johnston G.R. Prostatic disorders in the dog. Anim. Reprod. Sci. 60-61:2000;405-415.
11. Krawiec D.R., Heflin D. Study of prostatic disease in dogs: 177 cases (1981-1986). J. Am. Vet. Med. Assoc. 200:1992;1119-1122.
12. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1999, CA. Cancer J. Clin. 49:1999;6-29.
13. Leav I., King G.V. Adenocarcinoma of the canine prostate. Cancer. 22:1968;1329-1345.
14. Leav I., Schelling K.H., Adams J.Y., Merk F.B., Alroy J. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Prostate. 47:2001;149-163.
15. Lowseth L.A., Gerlach R.F., Gillet N.A., Muggenburg B.A. Age-related changes in the prostate and testes of the beagle dog. Vet. Pathol. 27:1990;347-353.
16. Mahapokai W., Xue Y., van Garderen E., van Sluijs F.J., Mol J.A., Schalken J.A. Cell kinetics and differentiation after hormonal-induced prostatic hyperplasia in the dog. Prostate. 44:2000;40-48.
17. Maini A., Archer C., Wang C.Y., Haas G.P. Comparative pathology of benign prostatic hyperplasia and prostate cancer. In Vivo. 11:1997;293-300.
18. McDonnell, J.D. 1991. The Pathophysiology of Benign Prostatic Hyperplasia.
19. McNeal J.E. Origin and evolution of benign prostatic enlargement. Invest. Urol. 15:1978;340-345.
20. McNeal J.E., Bostwick D.G., Kindrachuk R.A., Redwine E.A., Freiha F.S., Stamey T.A. Patterns of progression in prostate cancer. Lancet. i:1986;60-63.
21. Obradovich J., Walshaw R., Goullaud E. The influence of castration on the development of prostatic carcinoma in the dog. J. Vet. Int. Med. 1:1987;183-187.
22. Pilat M.J.P., Kamradt J.M., Pienta K.J. Hormone resistance in prostate cancer. Cancer Metastasis Rev. 17:1999;373-381.
23. Schoemaker N.J., Schuurmans M., Moorman H., Lumeij J.T. Correlation between age at neutering and age at onset of hyperdrenocorticism in ferrets. J. Am. Vet. Assoc. 216:2000;195-197.
24. Teske E., Nickel R.F. Zur Aussagekraft der Zytologie bei der Diagnostik des Prostatakarzinoms beim Hund. Kleintierpraxis. 41:1996;239-247.
25. Walsh P.C., Wilson J.D. The induction of prostatic hypertrophy in the dog with androstabediol. J. Clin. Inves. 57:1976;1093-1097.
26. Waters D.J., Patronek G.J., Bostwick D.G., Glickman L.T. Comparing the age at prostate cancer diagnosis in humans and dogs. J. Natl. Cancer Inst. 88:1996;1686-1687.
27. Waters D.J., Bostwick D.G. Prostatic intraepithelial neoplasia occurs spontaneously in the canine prostate. J. Urol. 157:1997;713-716.
28. Weaver A.D. Fifteen cases of prostatic carcinoma in the dog. Vet. Rec. 109:1981;71-75.
29. Winters S.J., Brufsky A., Weissfeld J., Trump D.L., Dyky M.A., Hadeed V. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism. 50:2001;1242-1247.
30. Wu A.H., Whittemore A.S., Kolonel L.N., John E.M., Gallagher R.P., West D.W., Hanki J., The C.Z., Dreon D.M., Paffenbarger R.S. Serum androgens and sex hormone-binding globulins in relation to lifestyle factor in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol. Biomarkers Prev. 4:1995;735-741.